Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

32
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
32
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

22
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
22
Cross-bridge Cycle01:26

Cross-bridge Cycle

108.7K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
108.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

49
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49
Amyloid Fibrils03:03

Amyloid Fibrils

10.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ.

JCI insight·2026
Same author

Protein disulfide isomerases in amyotrophic lateral sclerosis: Endoplasmic reticulum proteostasis and neuromuscular function.

Neural regeneration research·2026
Same author

Characterization of the mutational status of glioblastoma and high-grade astrocytomas in a Latin American cohort.

Scientific reports·2025
Same author

PKR-driven ISR signaling controls synaptic translation and structural plasticity in an age-dependent manner.

Neurobiology of disease·2025
Same author

Proteostasis decline and endoplasmic reticulum stress in aging: Implications for cellular senescence and senescence-associated secretory phenotype regulation.

Neural regeneration research·2025
Same author

Expression of amyotrophic lateral sclerosis associated protein disulfide isomerase A3 D217N variant recapitulates early morphological alterations at the neuromuscular junction.

Neurobiology of disease·2025

Related Experiment Video

Updated: Apr 28, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.5K

Common ground: stem cell approaches find shared pathways underlying ALS.

Soledad Matus1, Danilo B Medinas2, Claudio Hetz3

  • 1Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Independencia 1027, Chile; Neurounion Biomedical Foundation, Santiago, Chile.

Cell Stem Cell
|June 7, 2014
PubMed
Summary

Developing treatments for complex genetic diseases like Amyotrophic Lateral Sclerosis (ALS) is challenging due to a lack of effective disease models. New stem cell models show promise by mimicking key ALS features and revealing common disease pathways.

More Related Videos

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

6.4K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.0K

Related Experiment Videos

Last Updated: Apr 28, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.5K
Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

6.4K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.0K

Area of Science:

  • Neuroscience
  • Genetics
  • Stem Cell Biology

Background:

  • Genetically complex diseases, such as Amyotrophic Lateral Sclerosis (ALS), present significant challenges for therapeutic development.
  • A major hurdle has been the absence of accurate disease models that recapitulate key pathological features.

Purpose of the Study:

  • To investigate the utility of patient-derived induced-pluripotent-stem-cell-derived motoneurons (iPSC-MNs) as disease models for ALS.
  • To identify common pathogenic mechanisms across different ALS mutations using these novel models.

Main Methods:

  • Generation of iPSC-MNs from patients with various ALS-associated mutations.
  • Characterization of cellular and molecular phenotypes in patient-derived iPSC-MNs.
  • Comparative analysis of disease features and pathways across different genetic backgrounds.

Main Results:

  • Patient-derived iPSC-MNs successfully recapitulated hallmark features of ALS pathology.
  • Common molecular pathways were identified, suggesting convergent mechanisms in disease progression.
  • These models provide a platform for dissecting disease heterogeneity and identifying therapeutic targets.

Conclusions:

  • Induced-pluripotent-stem-cell-derived motoneurons represent a powerful tool for studying genetically complex neurological disorders like ALS.
  • The identification of shared pathways offers new avenues for developing broadly effective curative therapies.